{"id":"W4408185418","doi":"10.1016/j.carbpol.2025.123478","title":"Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform","year":2025,"lang":"en","type":"article","venue":"Carbohydrate Polymers","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Johansen Larsen Foundation; Helse Vest Regionalt Helseføretak; Barnekreftforeningen; China Scholarship Council; Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique; Agence Nationale de la Recherche; Kreftforeningen","keywords":"Nanocarriers; Liposome; Cyclodextrin; Chlorpromazine; Pharmacology; Drug; Repurposing; Medicine; Drug carrier; Chemistry; Chromatography; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001012657,0.0002664911,0.0001961168,0.0001835345,0.00009398803,0.000235654,0.0001610516,0.0002710758,0.00105318],"category_scores_gemma":[0.0001031822,0.0001271057,0.0002281444,0.0000981475,0.0001341469,0.0002298632,0.0002476011,0.0004368671,0.0005349464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003135519,"about_ca_system_score_gemma":0.000215434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004778272,"about_ca_topic_score_gemma":0.0005771765,"domain_scores_codex":[0.9999377,0.000007214766,0.000004940129,0.00001694393,0.00001894108,0.0000142932],"domain_scores_gemma":[0.9999707,0.000003129215,0.00001086036,0.000003032399,0.00000494869,0.000007267731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001322069,0.00004875355,0.00009616459,0.0001226641,0.00001171868,0.0001605723,0.00001979192,0.0004801201,0.9876604,0.0004090905,0.0004554427,0.01040294],"study_design_scores_gemma":[0.00005912274,0.0004153854,0.0005236349,0.00001411015,0.0000280166,0.000399102,0.00001337537,0.002952884,0.9811721,0.00007583774,0.01432856,0.00001788101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9317024,0.01089407,0.04328202,0.0008468829,0.0002023583,0.0006795751,0.001052438,0.000666099,0.01067411],"genre_scores_gemma":[0.972896,0.004367479,0.01659483,0.0002807424,0.00002473007,0.000246663,0.0005116043,0.00003520149,0.005042686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00105318,"threshold_uncertainty_score":0.003523231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01086774208059755,"score_gpt":0.2379439219355028,"score_spread":0.2270761798549052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}